Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic acid to reduce hospitalization for neonatal phototherapy
IRCT20190604043813N4Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ursodeoxycholic acid in neonatal hyperbilirubinemia, sponsored by Shiraz University of Medical Sciences. Started Aug 2021; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on IRCT20190604043813N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190604043813N4.